Transplantation and Cellular Therapy

Published by: Elsevier Inc.  

People

  1. Perales
    Perales
  2. Giralt
    Giralt
  3. Dahi
    Dahi
  4. Boelens
    Boelens
  5. Papanicolaou
    Papanicolaou
  6. Politikos
    Politikos
  7. Ponce
    Ponce
  8. Devlin
    Devlin
  9. Jakubowski
    Jakubowski
  10. Papadopoulos
    Papadopoulos

Groups

  1. Department of Medicine (35)
  2. Center for Hematologic Malignancies (28)
  3. Bone Marrow Transplant (27)
  4. Hematologic Malignancies, Division of (26)
  5. CTCR Scholars (11)
  6. Division of Subspecialty Medicine (9)
  7. MSK Grad Students (9)
  8. Master of Science in Clinical and Translational Cancer Research (9)
  9. Epidemiology and Biostatistics (8)
  10. GSK Faculty (8)
Search Within
  1. "2021"
Formats
  1. Journal Article (24)
  2. Guidelines (12)
  3. Editorial (2)
  4. Review (2)
Groups
  1. Department of Medicine (35)
  2. Center for Hematologic Malignancies (28)
  3. Bone Marrow Transplant (27)
  4. Hematologic Malignancies, Division of (26)
  5. CTCR Scholars (11)
  6. Division of Subspecialty Medicine (9)

More Groups

People
  1. Miguel-Angel Perales (12)
  2. Sergio Giralt (10)
  3. Craig Sauter (7)
  4. Christina Cho (6)
  5. Parastoo Dahi (6)
  6. Sean Devlin (6)

More People

Years
  1. 2021 (40)
Publishers
  1. Elsevier Inc. (40)

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation
    Guidelines

    Yong, M. K.; Shigle, T. L.; Kim, Y. J.; Carpenter, P. A.; Chemaly, R. F.; Papanicolaou, G. A.
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: Clinical and molecular genetic prognostic factors in a Nordic population
    Journal Article

    Wedge, E.; Werner Hansen, J.; Dybedal, I.; Creignou, M.; Ejerblad, E.; Lorenz, F.; Werlenius, O.; Ungerstedt, J.; Skov Holm, M.; Nilsson, L.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Hypomethylating agents and FLT3 inhibitors as maintenance treatment for acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation - A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Allen, C.; Mirza, A. S.; Grimshaw, A. A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Cho, C.; Tallman, M. S.; Zeidan, A. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Guidelines for pediatric unrelated cord blood transplantation - Unique considerations
    Guidelines

    Dahlberg, A.; Kurtzberg, J.; Boelens, J.; Martinez, C.; Carpenter, P.; Tewari, P.; American Society for Transplantation; Cellular Therapy Cord Blood Special Interest Group
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Planned granulocyte colony-stimulating factor adversely impacts survival after allogeneic hematopoietic cell transplantation performed with thymoglobulin for myeloid malignancy
    Journal Article

    Orfali, N.; Zhang, M. J.; Allbee-Johnson, M.; Boelens, J. J.; Artz, A. S.; Brunstein, C. G.; McNiece, I. K.; Milano, F.; Abid, M. B.; Chee, L.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Outcomes and utilization trends of front-line autologous hematopoietic cell transplantation for mantle cell lymphoma
    Journal Article

    Riedell, P. A.; Hamadani, M.; Ahn, K. W.; Litovich, C.; Murthy, G. S. G.; Locke, F. L.; Brunstein, C. G.; Merryman, R. W.; Stiff, P. J.; Pawarode, A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Oral proteasome inhibitor ixazomib for switch-maintenance prophylaxis of recurrent or late acute and chronic graft-versus-host disease after day 100 in allogeneic stem cell transplantation
    Journal Article

    Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S. M.; Soto, C.; Cho, C.; Dahi, P.; Giralt, S.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • A prospective cohort study comparing long-term outcomes with and without palifermin in patients receiving hematopoietic cell transplantation for hematologic malignancies
    Journal Article

    Saber, W.; Steinert, P.; Zhang, M. J.; Chen, M.; Pope, A.; Keating, A.; Wingard, J. R.; Ballen, K.; Stiff, P.; Perales, M. A.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2020 highly morbid forms report
    Journal Article

    Wolff, D.; Radojcic, V.; Lafyatis, R.; Cinar, R.; Rosenstein, R. K.; Cowen, E. W.; Cheng, G. S.; Sheshadri, A.; Bergeron, A.; Williams, K. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Outcomes of allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Sheth, A. H.; Vetsa, S.; Grimshaw, A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Tamari, R.; Tallman, M. S.; Rampal, R. K.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save

    • Transplantation and Cellular Therapy – authorized name for:

    Name ISSN / ISBN Publisher
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 Unknown
    Transplantation and Cellular Therapy 26666375 Unknown
    Transplantation and Cellular Therapy 2666-6375 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2020
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666375 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 2021
    Transplantation and Cellular Therapy 26666375 2024
    Transplantation and Cellular Therapy 26666375 Elsevier B.V.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6375 Elsevier Science, Inc.
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2023
    Transplantation and Cellular Therapy 26666375 The Authors
    Transplantation and Cellular Therapy 26666367 2022
    Transplantation and Cellular Therapy 26666367 The American Society for Transplantation and Cellular Therapy
    Transplantation and Cellular Therapy 26666367 Elsevier Inc.
    Transplantation and Cellular Therapy 26666367 2024
    Transplantation and Cellular Therapy 2666-6367 Elsevier Inc.
    Unknown (26666375) 26666375 Elsevier B.V.